Knee Replacement

The Central Institute of Orthopaedics (CIO), Vardhman Mahavir Medical College (VMMC) and Safdarjung Hospital, New Delhi, have achieved a significant milestone in advanced orthopaedic care with the successful performance of its first Robot-Assisted Total Knee Replacement (TKR).The introduction of robot-assisted orthopaedic surgery at CIO has been undertaken with the leadership, support and encouragement of Dr Kavita Sharma, Director, VMMC & Safdarjung Hospital. The initiative further strengthens the hospital's capacity to provide advanced, technology-enabled orthopaedic care within the public healthcare system.The procedure was performed under the clinical guidance of Prof. Dr Sumit Sural, Director, CIO, with the dedicated surgical team led by Dr Bhagwati Prasad Sharma, Consultant Professor & Head of Unit.The landmark procedure was performed completely free of cost under the Ayushman Bharat scheme on a 75-year-old economically disadvantaged male beneficiary at this Central .

A new Science study shows that blocking an ageing-linked protein can regenerate knee cartilage and prevent arthritis in mice, raising hopes of injections or pills that could delay joint replacement su

.

Given his condition and the need for a long-lasting, high-performance outcome, a team of experts led by Dr. Sujoy Bhattacharjee, Chairman of the Max Institute of Robotic Joint Replacement

India's orthopaedic and cardiac implant sector is expected to reach USD 4.5-5 billion by 2027-28, mainly driven by strong domestic demand and gradually growing exports, a report said on Monday. Currently, the orthopaedic and cardiac implant sector, including exports, stood at USD 2.4-2.7 billion in FY24, according to a report by CareEdge Ratings. The growth in the sector is led by increasing per capita income, greater healthcare awareness, ageing population, expanding healthcare infrastructure, and broadening insurance coverage, it stated. The report said that domestic manufacturers have grown at a faster pace than the dominant foreign MNCs in recent years, aided by their price competitiveness and a gradual build-up of an efficacy and safety track record. The segment is dominated by the presence of foreign multinational companies, which largely import the implants and sell them in India as the implant business requires strong technological capabilities, a proven track record of saf

The company claimed that at Rs 2 crore, MISSO is priced around 66 per cent lower than the available robotic knee replacement systems in the Indian market

Tips for healthy joints

Knee replacement is common in people above 50 years of age